13F Insight
DOSSIER · 13F Holders · Q2 2026
ELOX

ELOXX PHARMACEUTICALS INC

2 institutions still hold ELOXX PHARMACEUTICALS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 29014R301·2 13F holders·last filed Jun 30, 2026
Market cap
—
13F value held
$84
visible holders
Holders
2
filers reporting
Concentration
66.67%
Activest Wealth Management #1
top holder share
AI Holders Summary · Q2 2026

2 institutions reported ELOX in Q2 2026. Activest Wealth Management leads at 66.7% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
Activest Wealth Management
CIK 0001883134
$5640.00%Q2 202602
SBI Securities Co., Ltd.
CIK 0001851815
$2820.00%Q2 2026
Insiders at ELOXX PHARMACEUTICALS INC
Domicilium Real Estate Fund Iii Lp →Aggarwal Sumit →Rubin Steven D →Kjellson Nina S →Walts Alan Edmund →Webster Stephen W →Coastlands Capital Lp →Androski Lindsay →